can you take glp 1 with pancreatitis GLP-1 Agonists and Risk GLP-1 Medications and Pancreatitis: Important
Description
CagriSema is a fixed-dose combination of cagrilintide (an amylin analogue) and semaglutide (a GLP-1 receptor agonist), and is currently an experimental obesity drug developed by Novo Nordisk
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.
Is there a link between GLP-1 medications and pancreatitis

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity
FDA Ozempic warning focuses on labeling for side effects like thyroid tumors, pancreatitis, and vision changes

7 & 1